Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5690451 | 1.00 | CYP1A2 (0.49) | CYP1A2 | |
| SCHEMBL5435198 | 1.00 | CYP1A2 (0.49) | CYP1A2 | |
| SCHEMBL80633 | 0.93 | CYP1A2 (0.46) | CYP1A2 | |
| SCHEMBL81708 | 0.92 | CYP1A2 (0.44) | CYP1A2 | |
| SCHEMBL28350743 | 0.74 | CYP1A2 (0.47) | CYP1A2 | |
| SCHEMBL906614 | 0.74 | CYP1A2 (0.47) | CYP1A2 | |
| SCHEMBL3722471 | 0.74 | CYP1A2 (0.47) | CYP1A2 | |
| SCHEMBL7976411 | 0.72 | CYP1A2 (0.46) | CYP1A2 | |
| SCHEMBL20772142 | 0.71 | KDM4E (0.44) | CYP1A2 | |
| SCHEMBL28748031 | 0.70 | CYP1A2 (0.37) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3773445-B1 | RETINOL REPLACEMENT IN SKIN TREATMENT | SYMRISE AG (DE) | 2024-07-24 | — | — | EP | claimed |
| CN-111918637-A | Retinol substitute in skin treatment | 西姆莱斯有限公司 | 2020-11-10 | — | — | CN | claimed |
| EP-1959915-B1 | MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND ANTIDANDRUFF AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING | SYMRISE AG (DE) | 2015-05-13 | — | — | EP | claimed |
| EP-2276356-B1 | WARMING SENSATE COMPOSITION | FIRMENICH & CIE (CH) | 2013-06-19 | — | — | EP | claimed |
| US-12128257-B2 | Extracts of Isochrysis sp | SYMRISE AG (DE) | 2024-10-29 | — | — | US | disclosed |
| CN-118369431-A | Aptamer for personal healthcare applications | 宝洁公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-118355123-A | Aptamer for personal healthcare applications | 宝洁公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118355122-A | Aptamer for personal healthcare applications | 宝洁公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118339295-A | Aptamer for personal healthcare applications | 宝洁公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-117355218-A | Flavor beads and methods of making and using the same | 威·曼父子有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-116806825-A | Antimicrobial mixture | 西姆莱斯股份公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116546890-A | Liquid composition comprising cereal beta-glucan or cereal extract containing beta-glucan | 西姆莱斯股份公司 | 2023-08-04 | — | — | CN | disclosed |
| EP-2168570-A2 | Extracts of isochrysis sp. | Symrise GmbH & Co. KG (DE) | 2010-03-31 | — | — | EP | disclosed |
| WO-2010000877-A2 | FORMULATION WITH IRRITATION REDUCING ACTION COMPRISING BISABOLOL AND [6]-PARADOL | SYMRISE GMBH & CO. KG (DE) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009101216-A2 | OMEGA-CYCLOHEXYLALKAN-1-OLES AND USE THEREOF AS ANTIMICROBIAL ACTIVES TO COMBAT BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-08-20 | — | — | WO | disclosed |
| US-20090123392-A1 | FRAGRANCE ACCORDS TO COMBAT THE PERCEPTION OF BODY ODOR | SYMRISE GMBH & CO. KG (DE) | 2009-05-14 | — | — | US | disclosed |
| WO-2008119841-A2 | COMPOSITIONS COMPRISING BENZYL ALCOHOL DERIVATIVES AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2008-10-09 | — | — | WO | disclosed |
| US-20070010574-A1 | Use of a trpm8-activating substance for the treatment of tumours | PLATH THOMAS | 2007-01-11 | — | — | US | disclosed |
| EP-1575673-A2 | USE OF A TRPM8-ACTIVATING SUBSTANCE FOR THE TREATMENT OF TUMOURS | metaGen Pharmaceuticals GmbH (DE) | 2005-09-21 | — | — | EP | disclosed |
| WO-2004054497-A2 | USE OF A TRPM8-ACTIVATING SUBSTANCE FOR THE TREATMENT OF TUMOURS | METAGEN PHARMACEUTICALS GMBH (DE) | 2004-07-01 | — | — | WO | disclosed |